Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;26(1):e14183.
doi: 10.1111/tid.14183. Epub 2023 Nov 9.

Slaying the "Troll of Transplantation"-new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

Camille N Kotton  1 , Julian Torre-Cisneros  2   3 , Ibrahim Yakoub-Agha  4 ; CMV International Symposium Faculty
Collaborators, Affiliations
Review

Slaying the "Troll of Transplantation"-new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

Camille N Kotton et al. Transpl Infect Dis. 2024 Feb.

Abstract

The 2023 International CMV Symposium took place in Barcelona in May 2023. During the 2-day meeting, delegates and faculty discussed the ongoing challenge of managing the risk of cytomegalovirus infection (the Troll of Transplantation) after solid organ or hematopoietic cell transplantation. Opportunities to improve outcomes of transplant recipients by applying advances in antiviral prophylaxis or pre-emptive therapy, immunotherapy, and monitoring of cell-mediated immunity to routine clinical practice were debated and relevant educational clinical cases presented. This review summarizes the presentations, cases, and discussions from the meeting and describes how further advances are needed before the Troll of Transplantation is slain.

Keywords: CMV immunoglobulin; cell-mediated immunity; hematopoietic cell transplant; resistance; solid organ transplant; vaccines.

PubMed Disclaimer

References

REFERENCES

    1. Jorgenson MR, Descourouez JL, Wong C, et al. Cytomegalovirus antiviral stewardship in the COVID-19 era: increasing complexity of prophylaxis and treatment and potential mitigation strategies. Transpl Infect Dis. 2021;23(4):e13586.
    1. Yamamoto Y, Shiroyama T, Hirata H, et al. Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19. J Med Virol. 2022;94(3):1067-1073.
    1. Gatto I, Biagioni E, Coloretti I, et al. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. Intensive Care Med. 2022;48(6):706-713.
    1. Manuel O, Kralidis G, Mueller NJ, et al. Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2013;13(9):2402-2410.
    1. Stern M, Hirsch H, Cusini A, et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. Transplantation. 2014;98(9):1013-1018.

MeSH terms

Substances

Grants and funding